English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Oral bisphosphonate and breast cancer: prospective results from the Women's Health Initiative (WHI)
Share :
SABCS 2009
9 - 13 Sep 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
28 Jan 2010
Views:
8595
Rating:
Save
Rate video
Dr Rowan Chlebowski - Harbor-University of California, Los Angeles
Oral bisphosphonates directly inhibit breast cancer incidence. Official San Antonio Breast Cancer Symposium press conference.
Watch Dr Chlebowski presenting his research into oestrogen and progestin therapy at the ASCO 2009 press conference.
Categories:
Breast
Related Videos
Choosing Wisely for young women with breast cancer: BMC data
Dr Siddharth Turkar - Balco Medical Center, Raipur, India
22 Sep 2024
Choosing Wisely for young women with breast cancer: Radiotherapy
Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India
22 Sep 2024
Choosing Wisely for young women with breast cancer: Medical therapy
Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India
22 Sep 2024
ESMO 2024: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
16 Sep 2024
Mutational-based treatment approach may significantly improve outcomes in...
Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy
16 Sep 2024
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...
Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA
14 Sep 2024
Trastuzumab deruxtecan effective against brain metastases in HER2-positive...
Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA
14 Sep 2024
Patient reported outcomes for telisotuzumab vedotin in c-Met protein...
Prof Nicolas Girard - Institut Curie, Paris, France
14 Sep 2024
Breastfeeding after breast cancer is safe
Dr Eva Blondeaux - Ospedale San Martino, Genova, Italy
14 Sep 2024
More from
e
cancer